The tweet was deleted by the author.
But we saved everything 🙂.
CVRx is set to lead a session on integrating Barostim therapy into comprehensive heart failure programs at this week's AAHFN Annual Meeting.
The event, which will take place on Wednesday, June 24, will feature expert faculty sharing practical insights and real-world case studies. Attendees can expect to gain actionable knowledge about incorporating Barostim into clinical practice, with a focus on improving outcomes for heart failure patients.
CVRx recently achieved a milestone with the first Barostim implant at Huntsville Hospital, expanding device therapy options for heart failure. The company has also broadened Barostim therapy access for patients through a partnership with RWJBarnabas Health at Robert Wood Johnson University Hospital. These initiatives follow CVRx’s continued efforts to expand clinical use of its device.